IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MAZZAFERRO, VINCENZO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 34.803
AS - Asia 14.916
NA - Nord America 14.781
SA - Sud America 1.437
AF - Africa 291
OC - Oceania 234
Continente sconosciuto - Info sul continente non disponibili 26
Totale 66.488
Salva come PNG Salva come JPEG
Nazione #
DE - Germania 15.620
US - Stati Uniti d'America 14.003
CN - Cina 6.748
GB - Regno Unito 6.347
IT - Italia 4.550
SG - Singapore 2.395
FR - Francia 1.329
SE - Svezia 1.239
IN - India 1.150
RU - Federazione Russa 1.118
ES - Italia 1.011
IE - Irlanda 867
BR - Brasile 821
JP - Giappone 819
HK - Hong Kong 685
VN - Vietnam 659
TR - Turchia 648
CA - Canada 521
KR - Corea 452
NL - Olanda 425
FI - Finlandia 376
ID - Indonesia 354
TW - Taiwan 252
AR - Argentina 245
MX - Messico 212
AT - Austria 209
AU - Australia 207
DK - Danimarca 206
UA - Ucraina 198
GR - Grecia 185
CH - Svizzera 179
BE - Belgio 166
CO - Colombia 155
PT - Portogallo 147
TH - Thailandia 138
PL - Polonia 130
RO - Romania 109
IR - Iran 92
EG - Egitto 84
CL - Cile 80
PK - Pakistan 78
PH - Filippine 75
EU - Europa 72
NO - Norvegia 63
PE - Perù 58
MY - Malesia 54
RS - Serbia 53
HU - Ungheria 52
IL - Israele 48
SI - Slovenia 43
ZA - Sudafrica 43
CZ - Repubblica Ceca 38
EC - Ecuador 36
SA - Arabia Saudita 36
TN - Tunisia 36
MA - Marocco 29
NZ - Nuova Zelanda 26
BD - Bangladesh 24
HR - Croazia 23
SK - Slovacchia (Repubblica Slovacca) 23
IQ - Iraq 22
AE - Emirati Arabi Uniti 21
NP - Nepal 19
VE - Venezuela 19
BY - Bielorussia 17
JO - Giordania 17
LT - Lituania 17
KZ - Kazakistan 16
UZ - Uzbekistan 16
BG - Bulgaria 15
GT - Guatemala 15
NG - Nigeria 15
DZ - Algeria 14
LB - Libano 14
SC - Seychelles 13
BO - Bolivia 12
KE - Kenya 12
CY - Cipro 11
AZ - Azerbaigian 10
EE - Estonia 10
GH - Ghana 10
BF - Burkina Faso 8
KH - Cambogia 8
MK - Macedonia 8
UY - Uruguay 8
AL - Albania 7
MD - Moldavia 7
PR - Porto Rico 7
MO - Macao, regione amministrativa speciale della Cina 6
YE - Yemen 6
LK - Sri Lanka 5
LY - Libia 5
NI - Nicaragua 5
OM - Oman 5
BJ - Benin 4
BN - Brunei Darussalam 4
CR - Costa Rica 4
LU - Lussemburgo 4
LV - Lettonia 4
MN - Mongolia 4
Totale 66.465
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 13.905
Southend 5.481
Singapore 1.540
Chandler 1.319
Milan 1.267
Seattle 858
Princeton 852
Beijing 840
Dublin 834
Fairfield 749
Wilmington 741
Hangzhou 671
Council Bluffs 626
Ashburn 556
Shanghai 545
Houston 521
Nanjing 450
Ann Arbor 439
Redwood City 375
Woodbridge 346
Guangzhou 335
Bengaluru 304
Dearborn 299
Des Moines 295
Rome 277
Cambridge 266
Jakarta 259
Dong Ket 247
Santa Clara 245
New York 207
Toronto 204
Madrid 185
Boardman 177
Tokyo 171
Berlin 170
Jinan 170
Hong Kong 167
Barcelona 163
Istanbul 159
Central 156
Shenyang 156
Los Angeles 153
Paris 151
Seoul 149
Bologna 139
Helsinki 137
Nuremberg 135
London 133
São Paulo 133
Hanover 129
Wuhan 129
Buenos Aires 121
Taipei 119
Chengdu 115
Changsha 114
Ottawa 114
Phoenix 112
Chicago 109
Fuzhou 106
Tianjin 106
San Diego 104
Hyderabad 101
Munich 99
Nanchang 94
Hebei 87
Jacksonville 87
Redmond 85
Zhengzhou 85
Athens 84
Bogotá 82
Delhi 82
Andover 81
Mountain View 80
Vienna 78
Bühl 76
Brussels 73
Moscow 71
Pittsburgh 69
Mumbai 67
Naples 65
Padova 65
Silver Spring 64
Ankara 63
Bangkok 63
Hefei 62
Mexico City 61
Central District 60
Turin 60
Zurich 60
Amsterdam 58
Ho Chi Minh City 58
Chongqing 57
Fremont 56
Valencia 55
Florence 53
Grafing 51
Santiago 51
Lima 50
Verona 48
Duncan 47
Totale 42.723
Salva come PNG Salva come JPEG
Nome #
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference 2.828
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update 2.203
Liver resection and transplantation for intrahepatic cholangiocarcinoma 1.878
Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion 1.254
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant Fibroblast Growth Factor 19 Signaling as a Driver Event in Hepatocellular Carcinoma 1.155
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality 1.099
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 1.078
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 885
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice 821
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 795
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma 735
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification 581
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial 546
Defining Global Benchmarks for Laparoscopic Liver Resections: An International Multicenter Study 512
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 503
Importance of early nutritional screening in patients with gastric cancer 469
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 439
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-mutated Hepatocellular Carcinoma 398
Sorafenib in advanced hepatocellular carcinoma 379
Delaying surgery for patients with a previous SARS-CoV-2 infection 358
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant 354
Propensity-score Matched and Coarsened-exact Matched Analysis Comparing Robotic and Laparoscopic Major Hepatectomies: An International Multicenter Study of 4822 Cases 341
Transplantation of autologous extracellular vesicles for cancer-specific targeting 335
Endo-therapies for biliary duct-to-duct anastomotic stricture after liver transplantation: outcomes of a nationwide survey 312
Heterologous and cross-species tropism of cancer-derived extracellular vesicles 306
Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula : A Prospective Clinical Study 299
Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation 297
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma : subanalyses of a phase III trial 292
Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic : the SICE CLOUD19 Study 292
Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis: Tumor Biology Cuts the Deal 289
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection : an international cohort study 277
Resection of Retro-Hepatic Vena Cava (RHVC) En-bloc with Caudate Lobe without Vascular Exclusion for a Low Grade Leiomyosarcoma of Inferior Vena Cava 275
Liver transplantation for adenomatosis: European experience 255
A prospective randomized, open-labeled; trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma 250
Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors 250
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs 249
Thirty-day mortality and five-year survival in thoracic surgery: "real-world" assessment of outcomes from a single-institution audit 246
Propensity Score-Matching Analysis Comparing Robotic Versus Laparoscopic Limited Liver Resections of the Posterosuperior Segments: An International Multi-Center Study 240
Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study 240
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma : multicentre, open-label, phase II safety study 233
Post-liver transplant intrahepatic cholestasis : etiology, clinical presentation, therapy 225
Development of a prognostic scoring system for resectable hepatocellular carcinoma 224
Liver resection and transplantation for metastases from gastroenteropancreatic neuroendocrine tumors 222
Excellent 5-year overall survival in patients with HBV-related cirrhosis undergoing liver transplantation for hepatocellular carcinoma 215
Endoscopic ultrasound-guided fine needle aspiration of splenic vein thrombosis: a novel approach to the portal venous system 214
Strict selection alone of patients undergoing liver transplantation for hilar cholangiocarcinoma is associated with improved survival 213
Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry 211
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs) 211
Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach 204
EXTRACELLULAR VESICLES TO DELIVER THERAPEUTIC OR DIAGNOSTIC DRUGS 203
A modified technique of orthotopic transplant of the kidney in rabbits 202
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma 201
Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis 200
Immunotherapies for hepatocellular carcinoma 198
Endoscopic ultrasound-guided esophagoenterostomy for a completely obstructed surgical anastomosis 197
Comparison Between Swan-Ganz Catheter and Minimally Invasive Hemodynamic Monitoring During Liver Transplantation: Report of a Monocentric Case Series 197
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak : COVID-19-adapted Recommendations of the National Cancer Institute of Milan 197
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 195
Correction to: Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 194
ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA) 193
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma. 190
VESCICOLE EXTRACELLULARI PER VEICOLARE FARMACI TERAPEUTICI O DIAGNOSTICI 189
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients 188
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets 186
Clinical Behavior and Treatment Response of Epstein-Barr Virus–Positive Metastatic Gastric Cancer : Implications for the Development of Future Trials 185
Clinical impact of Pancreatic metastases from renal cell carcinoma : A multicenter retrospective analysis 183
Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies 183
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients with Metabolic Syndrome 182
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 179
Combination therapy with adefovir dipivoxil (ADV)and lamivudine (LAM) in LAM-resistant patients enlisted for liver transplantation 176
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma : available evidence and expert opinion on the use of transarterial chemoembolization 176
Thrombosis after liver transplantation for hepatocellular carcinoma 176
REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives 174
A multicenter italian experience in spli-liver transplantation : 10 year follow-up of a case control study 174
Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses 174
Succinate dehydrogenase B subunit immunohistochemical expression predicts aggressiveness in well differentiated neuroendocrine tumors of the ileum 174
Liver Match, a prospective observational cohort study on liver transplantation in Italy : study design and current practice of donor-recipient matching 173
Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma 173
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. 171
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis 170
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 170
A prospective policy development to increase split-liver transplantation for 2 adult recipients: Results of a 12-year multicenter collaborative study 168
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 168
Indocyanine Green Fluorescence-Guided Surgery for Gastrointestinal Tumors: A Systematic Review 165
Ki-67 and presence of liver metastases identify different progression-risk classes in pancreatic neuroendocrine neoplasms (pNEN) undergoing resection 165
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications 164
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation 163
Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry 162
Assessment of insulin sensitivity based on a fasting blood sample in men with liver cirrhosis before and after liver transplantation 161
Amino acid kinetics during the anhepatic phase of liver transplantation 159
COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy 159
GENOTIPI DELL'HCV IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO PER EPATOCARCINOMA SU CIRROSI 158
Proposal of Prognostic Survival Models before and after Liver Resection for Hepatocellular Carcinoma in Potentially Transplantable Patients. 157
Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms 157
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy : a phase II ITMO study 156
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 156
The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis 155
pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma 155
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable 155
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL) : a randomised, controlled, phase 2b/3 trial 155
Totale 35.448
Salva come PNG Salva come JPEG
Categoria #
all - tutte 167.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 167.375
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.246 0 0 0 0 0 0 0 0 0 642 307 297
2020/20215.775 335 371 423 306 510 596 360 434 661 437 530 812
2021/20226.655 439 367 244 474 473 446 516 521 753 696 480 1.246
2022/202310.475 799 603 520 1.168 1.195 1.717 939 1.082 799 379 707 567
2023/202416.716 474 591 649 668 1.205 880 2.354 2.047 1.109 2.018 2.366 2.355
2024/202514.841 2.339 2.651 2.083 1.923 1.060 912 984 1.730 1.148 11 0 0
Totale 69.507